(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study

Auteurs

A. Collignon, C. Houillier, G. Ahle, O. Chinot, S. Choquet, A. Schmitt, P. Agape, C. Soussain, K. Hoang-Xuan, Emeline Tabouret